바이오테크놀러지 성분 시장 - 규모, 점유율, 성장 분석 : 유형별, 제품 유형별, 발현 시스템별, 지역별 산업 예측(2026-2033년)

Global Biotech Ingredients Market size was valued at USD 2.39 Billion in 2024 and is poised to grow from USD 2.61 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The global market for biotech ingredients is experiencing significant growth, driven by the rising demand for sustainable and innovative solutions across diverse sectors, including pharmaceuticals, agriculture, and food production. Advances in biotechnology, particularly in areas like genetic engineering and synthetic biology, have facilitated the creation of bio-based ingredients, enzymes, and chemicals that provide improved performance and environmental advantages. Increased awareness of how biotech ingredients can tackle issues such as resource scarcity and climate change further supports their adoption. However, the market is shaped by challenges related to regulatory complexities and public perception, which play crucial roles in influencing its development and future opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is primarily driven by the increasing demand for sustainable and plant-based products. As consumers grow more aware of their health and environmental impacts, there is a noticeable shift toward products containing natural and eco-friendly ingredients. Biotechnology provides the capability to produce these ingredients through efficient and sustainable processes, thereby minimizing dependency on conventional agricultural techniques. This trend reflects consumers' preferences for clean labels and transparency, further boosting the uptake of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals. Overall, the emphasis on sustainability and health continues to shape market dynamics significantly.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable challenges due to regulatory hurdles and public skepticism regarding genetically modified organisms (GMOs). Despite advancements in biotechnology, lingering concerns about the safety, environmental implications, and ethical dimensions of GMOs contribute to apprehension among consumers and regulators alike. This atmosphere of doubt fosters stricter regulations and labeling mandates for biotech products, potentially hindering market expansion. To navigate these obstacles effectively, it is essential for industry participants to prioritize transparent communication, conduct thorough safety evaluations, and invest in educational initiatives aimed at building consumer trust and dispelling myths related to biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing transformative trends fueled by a rising consumer preference for sustainable and natural alternatives across multiple sectors, including food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing are leading to the creation of unique, high-performance ingredients, enhancing product offerings. Concurrently, supportive regulatory frameworks are nurturing an environment ripe for biotech advancements, with strategic partnerships between biotech companies and traditional manufacturers enhancing integration into mainstream products. This landscape reflects a broader shift towards bio-based solutions, aligning with the values of environmentally conscious consumers and driving the market toward a more sustainable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2026-2033)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2026-2033)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2026-2033)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations